👥
0
🟢
0
KAT6A Antibody Market: How Is Rare Disease Research Driving KAT6A Antibody Demand?
Rare disease research driving KAT6A antibody market development — the growing scientific investigation of KAT6A syndrome — a rare neurodevelopmental disorder caused by pathogenic variants in the KAT6A gene (encoding lysine acetyltransferase 6A, also known as MOZ or MYST3) — where affected individuals present with intellectual disability, speech delay, cardiac defects, feeding...
0 Yorumlar 0 Paylaşımlar 24 Görüntülenme 0 İncelemeler
Sponsorlu

Ask ME!

Meet @froq — your AI companion for instant answers, smart conversations, creative ideas, and real-time help. Just mention @froq and start chatting. 🚀